The privatisation offer for this small Catalist company could cause SGX some discomfort
The proposal to take Singapore Paincare private comes a mere five years after IPO, and highlights the local bourse’s chronic lack of liquidity
[SINGAPORE] Amid a flurry of delistings from the Singapore Exchange (SGX), one more privatisation offer – especially that for a small Catalist player – should not make much of a difference.
After all, the local bourse looks on pace to hit at least 20 delistings or privatisation offers in the first half of this year.
Already, firms such as offshore oil-and-gas contractor Dyna-Mac and software company Silverlake Axis have delisted this year.
TRENDING NOW
Qatari LNG ship struck in Strait of Hormuz, testing US talks
DBS, OCBC and UOB shares hit all-time highs as sentiment improves
‘Baptism of fire’: Andre Khor on leading Singapore refiner Aster through an energy crisis
Singapore retains top spot as most expensive city for HNWIs, with five Apac cities in global top 10